In Graves disease, thyroid-stimulating autoantibodies activate the thyrotropin receptor (TSHR), leading to increased thyroid hormone secretion and clinical thyrotoxicosis, but the exact molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback